Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.04.21	MÄRKTE USA/Uneinheitlich - Techwerte vorn (Dow Jones)
13.04.21	MÄRKTE USA/Wall Street mit steigender Inflation uneinheitlich (Dow Jones)
13.04.21	MÄRKTE USA/Wall Street kaum verändert gesehen - Inflation steigt (Dow Jones)
07.04.21	Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company (Businesswire)
29.03.21	Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call (Businesswire)
16.03.21	Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium (Businesswire)
11.03.21	Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions (Businesswire)
09.03.21	Simulations Plus to Present at Oppenheimer Healthcare Conference (Businesswire)
23.02.21	Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration (Businesswire)
11.02.21	Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference (Businesswire)
09.02.21	Simulations Plus Releases GastroPlus® Version 9.8.1 (Businesswire)
02.02.21	Simulations Plus Enters Agreement with Distributor in China (Businesswire)
26.01.21	Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences (Businesswire)
14.01.21	Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics (Businesswire)
12.01.21	Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference (Businesswire)
12.01.21	Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments (Businesswire)
11.01.21	Simulations Plus Reports Record First Quarter FY2021 Financial Results (Businesswire)
09.01.21	Ausblick: Simulations Plus legt Zahlen zum jüngsten Quartal vor (finanzen.net)
05.01.21	Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides (Businesswire)
04.01.21	Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call (Businesswire)
16.12.20	Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report (Businesswire)
03.12.20	DILIsym Services Presents Important DILIsym and NAFLDsym Software Applications at the Virtual AASLD Liver Meeting (Businesswire)
01.12.20	Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer (Businesswire)
16.11.20	Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results (Businesswire)
14.11.20	Ausblick: Simulations Plus vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
10.11.20	DILIsym Plays Critical Role in Submission to State of California for Common Analgesic Carcinogenicity Risk Assessment (Businesswire)
09.11.20	Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call (Businesswire)
05.11.20	Simulations Plus to Participate in the Credit Suisse Virtual Healthcare Conference (Businesswire)
03.11.20	Lixoft Expands MonolixSuite™ in Version 2020R1 (Businesswire)
27.10.20	First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review (Businesswire)
20.10.20	Simulations Plus Releases GastroPlus® Version 9.8 (Businesswire)
13.10.20	Simulations Plus Teams Up with the University of Health Sciences and Pharmacy in St. Louis to Secure New Grant Award from the U.S. FDA (Businesswire)
13.10.20	Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share (Businesswire)
29.09.20	Simulations Plus Extends Partnership with Large Pharmaceutical Company to Further Expand High-Throughput PBPK Capabilities in ADMET Predictor® (Businesswire)
22.09.20	Simulations Plus Partners with Large Pharmaceutical Company to Validate AI-Driven Drug Design Capabilities in ADMET Predictor® (Businesswire)
15.09.20	Simulations Plus Releases ADMET Predictor® Version 10.0 (APX) (Businesswire)
02.09.20	FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations (Businesswire)
31.08.20	Simulations Plus to Present at the LD 500 Virtual Conference (Businesswire)
10.08.20	Simulations Plus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares (Businesswire)
06.08.20	Simulations Plus Announces Pricing of $100 Million Underwritten Offering of Common Stock (Businesswire)
04.08.20	Simulations Plus Announces Proposed Underwritten Public Offering (Businesswire)
09.07.20	After Market Hours: Spartan Energy, PriceSmart, Simulations Plus Gain; WD-40, Franklin Covey Slip (RTTNews)
09.07.20	Simulations Plus Reports Third Quarter FY2020 Financial Results (Businesswire)
08.07.20	Ausblick: Simulations Plus präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
02.07.20	Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call (Businesswire)
29.05.20	ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch (RTTNews)
28.05.20	Simulations Plus Receives New Grant Award from the FDA (Businesswire)
21.05.20	Simulations Plus to Present at 17th Annual Craig-Hallum Institutional Investor Conference (Businesswire)
13.05.20	Simulations Plus to Present at 15th Annual Needham Virtual Technology & Media Conference (Businesswire)
02.04.20	Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’281.50	1.14 %	K V
Kuehne+Nagel Int	203.40	0.39 %	K V
Alcon	76.58	0.34 %	K V
Holcim	89.00	0.16 %	K V
Lonza Grp	541.40	0.00 %	K V
Sika	223.80	-1.06 %	K V
Swisscom	501.50	-1.08 %	K V
Swiss Re	129.70	-1.71 %	K V
Givaudan	3’981.00	-1.97 %	K V
Nestle	73.72	-1.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten